Reversal of Multidrug Resistance in an Epirubicin-Resistant Gastric Cancer Cell Subline

BACKGROUND: Gastric cancer is one of the most common malignancies worldwide. Epirubicin (EPI) is used extensively in the treatment of multiple cancers despite its tendency to induce multidrug resistance though overexpression of the ABCB1 efflux pump. However, this overexpression can be disrupted usi...

Descripción completa

Detalles Bibliográficos
Autores principales: Felipe, Aledson Vitor, de Oliveira, Juliana, Moraes, Andrea Aparecida, de França, Jerônimo Pereira, da Silva, Tiago Donizetti, Forones, Nora Manoukian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031827/
https://www.ncbi.nlm.nih.gov/pubmed/29801407
http://dx.doi.org/10.22034/APJCP.2018.19.5.1237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031827/
https://www.ncbi.nlm.nih.gov/pubmed/29801407
http://dx.doi.org/10.22034/APJCP.2018.19.5.1237

Ejemplares similares